Allogeneic Mesenchymal Stem Cells Can Mitigate Early, Ongoing, and Severe Graft Versus Host Disease but Require Delayed Administration for Optimal Effect.
Year: 2005
Type: article
Source: Blood
Authors: D. Polchert, J. Sobinsky, M. Kidd, A. Moadsiri, E. Reina, K. Genrich, A. Bartholomew
Institution: University of Illinois Chicago
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2573377808